Hantz Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Hantz Financial Services's JAZZ Position: Q2 2026 in Review
Hantz Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q2 2026, buying an estimated $146K and bringing the position to 3,961 shares worth $954K. The position accounts for 0.01% of the portfolio, ranked #526.
Hantz Financial Services first reported a position in JAZZ in Q1 2020 and has held it in 22 quarters since. The position peaked at $3.02M in Q1 2020. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Hantz Financial Services held 3,961 shares of Jazz Pharmaceuticals worth $954K as of Q2 2026.
- Hantz Financial Services bought 668 Jazz Pharmaceuticals shares in Q2 2026, an estimated $146K.
- Jazz Pharmaceuticals made up 0.01% of Hantz Financial Services's portfolio in Q2 2026, its #526 holding.
- Hantz Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 22 quarters since.
- Hantz Financial Services's Jazz Pharmaceuticals position peaked at $3.02M in Q1 2020.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.